Tourmaline US-MM6, an Open-Label, Single-Arm, Multicenter Study Evaluating the Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) in Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) Switching from a Bortezomib-Based Triplet Induction Regimen
Rifkin, Robert M, Boccia, Ralph V., Kambhampati, Suman, Richter, Joshua R, Usmani, Saad Z, Aiello, Jack, Sickler, Brittany, Schoeneich, Magdalena, Wang, Bingxia, Zelt, Susan, Whidden, Presley, Dollar, Lawrence E, Niculescu, Liviu, Noga, Stephen J
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Uncovering the Blind Spot of Clinical Trials: First Report of Baseline Characteristics of Newly Diagnosed (ND) and Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients (Pts) in Insight-MM, a Global, Prospective, Observational Study
Terpos, Evangelos, Chari, Ajai, Rifkin, Robert M, Abonour, Rafat, Berdeja, Jesus G., Boccadoro, Mario, Cook, Gordon, Costello, Caitlin, Girnius, Saulius, Goldschmidt, Hartmut, Hájek, Roman, Hungria, Vania T M, Lee, Hans C., Leleu, Xavier, Omel, Jim, Spencer, Andrew, Thompson, Michael A, Usmani, Saad Z, Vela-Ojeda, Jorge, Zonder, Jeffrey A, Niculescu, Liviu, Noga, Stephen, Skacel, Tomas, Cacioppo, Roxanne, Sickler, Brittany, Yu, Shawn, Ren, Kaili, Luptakova, Katarina, Stull, Dawn Marie, Davies, Faith E.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article